Review
doi: 10.1586/14737140.6.3.383.
Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma
Affiliations
- PMID: 16503855
- DOI: 10.1586/14737140.6.3.383
Item in Clipboard
Review
Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma
Expert Rev Anticancer Ther.
2006 Mar.
Abstract
Nasopharyngeal carcinoma (NPC) is endemic in Asia and is etiologically associated with the Epstein-Barr virus. Although radiotherapy can cure most patients with early-stage disease, those with advanced disease often develop recurrences following radiotherapy. The past decade has witnessed significant advances in the systemic treatment of advanced NPC. This article reviews the latest literature regarding: combined modality therapy for locoregionally advanced NPC; clinical trials of novel biologic and cytotoxic therapies for metastatic NPC; and disease monitoring with the plasma Epstein-Barr virus DNA assay.
Similar articles
-
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347
-
[Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].Ai Zheng. 2006 Jul;25(7):785-92. Ai Zheng. 2006. PMID: 16831265 Chinese.
-
Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?Nat Clin Pract Oncol. 2005 Jan;2(1):14-5. doi: 10.1038/ncponc0051. Nat Clin Pract Oncol. 2005. PMID: 16264847 No abstract available.
-
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.Cancer. 2005 Jan 1;103(1):22-31. doi: 10.1002/cncr.20768. Cancer. 2005. PMID: 15565580 Review.
-
Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.Cancer Treat Rev. 2009 Jun;35(4):345-53. doi: 10.1016/j.ctrv.2009.01.002. Epub 2009 Feb 10. Cancer Treat Rev. 2009. PMID: 19211192 Review.
Cited by
-
Impact of Neoadjuvant Chemotherapy on the Administration of Concurrent Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma.Cureus. 2018 Jul 12;10(7):e2971. doi: 10.7759/cureus.2971. Cureus. 2018. PMID: 30280053 Free PMC article.
-
The Super-scan and Flare Phenomena in a Nasopharyngeal Cancer Patient: A Case Report.J Clin Med Res. 2012 Jun;4(3):221-3. doi: 10.4021/jocmr820w. Epub 2012 May 15. J Clin Med Res. 2012. PMID: 22719811 Free PMC article.
-
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.Cancer Immunol Immunother. 2022 Nov;71(11):2583-2596. doi: 10.1007/s00262-022-03183-8. Epub 2022 Mar 17. Cancer Immunol Immunother. 2022. PMID: 35299256 Free PMC article.
-
Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.Neoplasia. 2008 Nov;10(11):1183-94. doi: 10.1593/neo.08590. Neoplasia. 2008. PMID: 18953427 Free PMC article.
-
Estimating the global burden of Epstein-Barr virus-related cancers.J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46. doi: 10.1007/s00432-021-03824-y. Epub 2021 Oct 27. J Cancer Res Clin Oncol. 2022. PMID: 34705104 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
